Addressing bioterrorism concerns: Options for investigating the mechanism of action of Staphylococcus aureus enterotoxin B

Human and Experimental Toxicology

Volumn 32, Issue 6, 2013, Pages 606-619

  Lindsay, C D ^a   Griffiths, G D ^a  

^a Biomedical Sciences Department   (United Kingdom)

Author keywords

bioterrorism; cytokines; In vitro models; in vivo models; medical countermeasures; MHC class II receptors; peripheral blood mononuclear cells; staphylococcal enterotoxin B; threat agent

Indexed keywords

APC; CELL SURFACE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RAPAMYCIN; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1;

ARTICLE; BIOLOGICAL WARFARE AGENT; CROSS LINKING; CYTOKINE PRODUCTION; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MECHANISM; FOOD POISONING; HUMAN; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TISSUE INJURY; TOXIC SHOCK SYNDROME; VOMITING;

ANIMALS; BIOTERRORISM; CASPASE INHIBITORS; COCULTURE TECHNIQUES; DEXAMETHASONE; ENTEROTOXINS; EPITHELIAL CELLS; HUMANS; MACACA MULATTA; MICE; MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL; STAPHYLOCOCCUS AUREUS;

ANIMALIA; PRIMATES; STAPHYLOCOCCUS AUREUS;

EID: 84878300936     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112458941     Document Type: Article

References (108)

1. Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002 ; 323: 326-340
2. Le Loir Y, Baron F, Gautier M.. Staphylococcus aureus and food poisoning. Genet Mol Res. 2003 ; 2: 63-76
3. Ulrich RG, Sidell S, Taylor TJ, Wilhelmsen CL, Franz DR. Staphylococcal enterotoxin B and related pyrogenic toxins. Medical aspects of chemical and biological warfare. Zajtchuk R Bellamy RF, ed. Washington, DC: Office of the Surgeon General, US Department of the Army ; 1997: 621-630.
4. Krakauer T, Stiles BG. Staphylococcal enterotoxins, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: some basic biology of bacterial superantigens. Recent Res Devel Infect Immun. 2003 ; 1: 1-27
5. Bavari S, Ulrich RG. Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatability complex class II binding. Infect Immun. 1995 ; 63: 423-429
6. Bergdoll MS. Enterotoxins. Microbial toxins. Montie TC Kadis S Ajl SJ, ed. New York: Academic Press ; 1970: 265-326.
7. Mahmood R, Khan SA. Role of upstream sequences in the expression of the staphylococcal enterotoxin B gene. J Biol Chem. 1990 ; 265: 4652-4656
8. Jett M, Neill R, Welch C, Boyle T, Bernton E, Hoover D, et al. Identification of staphylococcal entreotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect Immun. 1994 ; 62: 3408-3415
9. Charlier C, Cretenet M, Even S, Le Loir Y. Interactions between Staphylococcus aureus and lactic acid bacteria: an old story with new perspectives. Int J Food Microbiol. 2009 ; 131: 30-39
10. Fernandez-Saiz P, Soler C, Lagaron JM, Ocio MJ. Effects of chitosan films on the growth of Listeria monocytogenes, Staphylococcus aureus and Salmonella spp in laboratory media and in fish soup. Int J Food Microbiol. 2010 ; 137: 287-294
11. Gaupp R, Schlag S, Liebeke M, Lalk M, Götz F. Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. J Bacteriol. 2010 ; 192: 2385-2394
12. Geiger T, Goerke C, Fritz M, Schäfer T, Ohlsen K, Liebeke M, et al. Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect Immun. 2010 ; 78: 1873-1883
13. Chlebowicz M, Nganou K, Kozytska S, Arends JP, Engelmann S, Grundmann H, Ohlsen K, van Dijl JM, Buist G. Recombination between ccrC genes in a type V (5C2&5) staphylococcal cassette chromosome mec (SCCmec) of Staphylococcus aureus ST398 Leads to conversion from methicillin resistance to methicillin susceptibility in vivo. Antimicrob Agents Ch. 2010 ; 54: 783-791
14. Pepe O, Blaiotta G, Bucci F, Anastasio M, Aponte M, Villani F. and Staphylococcus aureus and staphylococcal enterotoxin A in breaded chicken products: detection and behavior during the cooking process. Appl Environ Microb. 2006 ; 72: 7057-7062
15. Nkwelang G, Akoachere JFTK, Kamga LH, Nfoncham ED, Ndip RN. Staphylococcus aureus isolates from clinical and environmental samples in a semi-rural area of Cameroon: phenotypic characterization of isolates. Afr J Microbiol Res. 2009 ; 3: 731-736
16. Devriese LA. A simplified system for biotyping Staphylococcus aureus strains isolated from different animal species. J Appl Bacteriol. 1984 ; 56: 215-220
17. Adekeye D. Enterotoxin production by strains of Staphylococcus aureus isolated from animals and man in Nigeria. Vet Microbiol. 1980 ; 5: 143-150
18. Derzelle S, Dilasser F, Duquenne M, Deperrois V. Differential temporal expression of the staphylococcal enterotoxins genes during cell growth. Food Microbiol. 2009 ; 26: 896-904
19. Otero A, García ML, García MC, Moreno B, Bergdoll MS. Production of staphylococcal enterotoxins C1 and C2 and thermonuclease throughout the growth cycle. Appl Environ Microbiol. 1990 ; 56: 555-559
20. Czop JK, Bergdoll MS. Staphylococcal enterotoxin synthesis during the exponential, transitional, and stationary growth phases. Infect Immun. 1974 ; 9: 229-235
21. Onoue Y, Mori M. Amino acid requirement for growth and enterotoxin production by Staphylococcus aureus in chemically defined media. Int J Food Microbiol. 1997 ; 36: 77-82
22. Melconian AK, Flandrois JP, Fleurette J. Modified method for production and purification of Staphylococcus aureus enterotoxin B. Appl Environ Microb. 1983 ; 45: 1140-1143
23. Staphylococcal Enterotoxin B: essential data. Available at: www.cbwinfo.com/Biological/Toxins/SEB.html(accessed 18 November 2011).
24. LeClaire RD, Hunt RE, Bavari S, Estep JE, Nelson GO, Wilhelmsen CL. Potentiation of inhaled staphylococcal enterotoxin B-induced toxicity by lipopolysaccharide in mice. Toxicol Pathol. 1996 ; 24: 619-626
25. Papageorgiou AC, Tranter HS, Acharya KR. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol. 1998 ; 277: 61-79
26. Hursh S, McNally R, Fanzone J, Mershon M Staphylococcal enterotoxin B battlefield challenge modelling with medical and non-medical countermeasures. Technical Report MBDRP-95-2, 1995. Joppa, MD: Science Applications International Corp.
27. Madsen JM.. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med. 2001 ; 21: 593-605
28. Moore P, Lindsay J. Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: evidence of horizontal transfer of virulence genes. J Clin Microbiol. 2001 ; 39: 2760-2767
29. Warner J, Onderdonk B. Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates. Appl Environ Microbiol. 2004 ; 70: 6931-6935
30. Leyden JJ, McGinley KJ, Nordstrom KM, Webster GF.. Skin microflora. J Invest Dermatol. 1987 ; 88: 65s - 72s
31. Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J. 2012 ; 9: 14-32
32. Shin K, Lee TR, Lee E, Jeong YH, Yun Y, Park TH, et al. Staphylococcus aureus in relation to physical, physiological and subjective conditions of apparently normal human skin. J Dermatol Sci. 2011 ; 63: 201-203
33. Nada HA, Gomaa NIM, Elakhras A, Wasfy R, Baker RA. Skin colonisation by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level. Int J Infect Dis. 2012 ; 16: e29 - e33
34. Cole GW, Silverberg NL. The adherence of Staphylococcus aureus to human comeocytes. Arch Dermatol. 1986 ; 122: 166-169
35. Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DYM. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis. 2008 ; 46: 1562-1567
36. Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin N Am. 2009 ; 23: 35-52
37. Kluytsman J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997 ; 13: 505-520
38. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol. 1996 ; 132: 27-33
39. Noble WC Microbiology of human skin. 2 nd ed. London: Lloyd-Luke, 1981.
40. Jager MM, Murk JLAN, Pique R, Wulf MWH, Leenders ACAP, Buiting AG, et al. Prevalence of carriage of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in employees of five microbiology laboratories in the Netherlands. J Hosp Infect. 2010 ; 74: 292-294
41. Udo EE, Al-Bustan MA, Jacob LE, Chugh TD. Enterotoxin production by coagulase-negative staphylococci in restaurant workers from Kuwait city may be a potential cause of food poisoning. J Med Microbiol. 1999 ; 48: 819-823
42. Røder BL, Eriksen NH, Nielsen LP, Slotsbjerg T, Rosdahl VT, Espersen F. No difference in enterotoxin production among Staphylococcus aureus strains isolated from blood compared with strains isolated from healthy carriers. J Med Microbiol. 1995 ; 42: 43-47
43. Bradley SF. Staphylococcus aureus infections and antibiotic resistance in older adults. Aging Infect Dis. 2002 ; 34: 211-216
44. Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, et al. Active surveillance for toxic shock syndrome in the United States. Rev Infect Dis. 1989 ; 11: S28 - S34
45. Emori TG, Banerjee SN, Culver DH, Gaynes RP, Horan TC, Edwards JR, et al. Nosocomial infections in elderly patients in the United States, 1986-1990. Am J Med. 1991 ; 91 (Suppl 3B). 289S - 293S
46. Infection. www.infectioncontroltoday.com/articles/2002/04/fighting- surgical-site-infections. (2002, accessed 20 March 2012).
47. Wolcott RD, Gontcharova V, Sun Y, Zischakau A, Dowd SE. Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care. 2009 ; 18: 317-323
48. Kalenić S, Zele-Starcević L, Jarza-Davila N, Jandrlić M. Infections in war injuries. Lijec Vjesn. 1991 ; 113: 233-235
49. Gottrup F. Wound closure techniques. J Wound Care. 1999 ; 8: 397-400
50. LeaperDJ andGottrup F. Surgicalwounds. In: LeaperDJ and Harding KG (ed) Wound biology and management. Oxford: Oxford University Press, 1998, pp. 23-40.
51. Heriazon A, Zhou P, Borojevic R, Foerster K, Streutker CJ, Hg T, et al. Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitis. Infect Immun. 2009 ; 77: 707-713
52. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. P Natl Acad Sci USA. 1989 ; 86: 8941-8945
53. Roitt I, Brostoff J, Male D. Immunology. Edinburgh, London, Melbourne, New York: Churchill Livingston ; 1985: 11.
54. Debbabi H, Ghosh S, Kamath AB, Alt J, deMello DE, Dunsmore S, et al. Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ cells. Am J Physiol Lung C. 2005 ; 289: 274-279
55. Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4 (+) T cells and induce Foxp3(+) regulatory T cells. Am J Resp Crit Care. 2009 ; 179: 344-355
56. Monday SR, Bohach GA. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J Clin Microbiol. 1999 ; 37: 3411-3414
57. Smith LA. Bacterial protein toxins as biological weapons. The comprehensive sourcebook of bacterial protein toxins. Alouf JE Popoff MR, ed. Burlington: Elsevier ; 2006: 1019-1030.
58. Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM. The TCR Vβ signature of bacterial superantigens spreads with stimulus strength. Int Immunol. 2006 ; 18: 1433-1441
59. Pang LTY, Kum WWS, Chow AW. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumour necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun. 2000 ; 68: 3261-3268
60. Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB. Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol. 1995 ; 23: 262-268
61. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: mechanism of T cell stimulation and role in immune responses. Ann Rev Immunol. 1991 ; 9: 745-772
62. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet. 2009 ; 9: 281-290
63. Boyle T, Lancaster V, Hunt R, Gemski P, Jett M. Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonic metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice. Anal Biochem. 1994 ; 216: 373-382
64. Jett M, Brinkley W, Neill R, Gemski P, Hunt R.. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun. 1990 ; 58: 3494-3499
65. Parsonnet J. Mediators in the pathogenesis of TSS: overview. Rev Infect Dis. 1989 ; 11: S263 - S269
66. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, et al. Prognostic values of tumour necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis. 1990 ; 161: 982-987
67. Nooh MM, El-Gengehi N, Kansal R, David CS, Kotb M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J Immunol. 2007 ; 178: 3076-3083
68. Ragagopalan G, Tilahun AY, Asmann YW, David CS. Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor. Physiol Genomics. 2009 ; 37: 279-293
69. Kotzin BL, Leung DYM, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993 ; 54: 99-166
70. Kain KC, Schulzer M, Chow AW. Clinical spectrum of nonmenstrual toxic shock syndrome (TSS); comparison with menstrual TSS by multivariate discriminant analysis. Clin Infect Dis. 1993 ; 16: 100-106
71. Minor TE, Marth EH.. Staphylococcus aureus and staphylococcal food intoxications. A review. II. Enterotoxins and epidemiology. J Milk Food Technol. 1971 ; 35: 21-29
72. Kumar V, Abbas AK, Fausto N, Aster JC Robbins and Cotran Pathologic Basis of Disease. Philadelphia, PA: Saunders Elsevier ; 2010: 53-54.
73. Folkerts G, Kloek J, Muijsers RBR, Nijkamp FP. Reactive nitrogen and oxygen species in airway inflammation. Eur J Pharmacol. 2001 ; 429: 251-262
74. Goldstone SD, Hunt NH. Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta. 1997 ; 1355: 353-360
75. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity. 1999 ; 10: 735-744
76. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Willliams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med. 2002 ; 195: 59-70
77. Buxser S, Vroegop S. Staphylococcal enterotoxin B stimulation of BALB/c lymphocyte mitogenesis and potential relationship to the Mls response. J Immunogenet. 1988 ; 15: 153-159
78. Shands JW, Peavy DL, Smith RT. Differential morphology of mouse spleen cells stimulated by endotoxin, phytohemagglutinin, pokeweed mitogen and staphylococcal enterotoxin B. Am J Pathol. 1973 ; 70: 1-24
79. Peavy DL, Adler WH, Smith RT. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol. 1970 ; 105: 1453-1458
80. Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model. Res Vet Sci. 2009 ; 86: 241-247
81. Krakauer T, Buckley M, Issaq HJ, Fox SD. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrob Agents Chemother. 2010 ; 54: 1125-1131
82. Bergdoll MS Staphylococcus aureus Food-borne bacterial pathogens. Doyle MP, ed. New York, NY: Marcel Dekker Inc ; 1989: 464-523.
83. Bergdoll MS. The staphylococcal enterotoxins. Biochemistry of some foodborne microbial toxins. Mateles RI Wogan GN, ed. Cambridge: MIT Press ; 1967: 1-25.
84. Hu DL, Omoe K, Shimoda Y, Nakane A, Shinagawa K. Induction of emetic response to staphylococcal enterotoxins in the house musk shrew (Suncus murinus). Infect Immun. 2003 ; 71: 567-570
85. Wright A, Andrews P, Titball RW. Induction of emetic, pyrexic, and behavioural effects of Staphylococcus aureus enterotoxin B in the ferret. Infect Immun. 2000 ; 68: 2386-2389
86. Cunningham AC, Zhang JG, Moy JV, Ali S, Kirby JA. A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology. 1997 ; 91: 458-463
87. Krakauer T, Stephens J, Buckley M, Tate M. Superantigen-induced cytokine release from whole-blood cell culture as a functional measure of drug efficacy after oral dosing in nonhuman primates. Res Vet Sci. 2007 ; 83: 182-187
88. Krakauer T. Caspase inhibitors attenuate superantigen- induced inflammatory cytokines, chemokines and T-cell proliferation. Clin Diagn Lab Immun. 2004 ; 11: 621-624
89. Krakauer T. Measurement of proinflammatory cytokines and T-cell proliferative response in superantigen-activated human peripheral blood mononuclear cells. Methods Mol Biol. 2003 ; 214: 137-149
90. Krakauer T, Buckley M. Doxycycline is anti- inflammatory and inhibits staphylococcal extoxin- induced cytokines and chemokines. Antimicrob Agents Chemother. 2003 ; 47: 3630-3633
91. Krakauer T, Li BQ, Young HA. The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Lett. 2001 ; 500: 52-55
92. Krakauer T. Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chenokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells. Clin Diagn Lab Immunol. 2001 ; 8: 449-453
93. Krakauer T. Coordinate suppression of superantigen- induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatability complex and CD4 interaction. Antimicrob Agents Chemother. 2000 ; 44: 1067-1069
94. Macildowie SD, Lindsay CD, Inns RH. Use of gene microarrays to determine the effect of RF exposure on a human cell line 1. Dstl/Technical Report TR26820 V1, 2008. Porton Down, UK: Defence Science and Technology Laboratory.
95. See RH, Chow AW. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect Immun. 1992 ; 60: 3456-3459
96. Komuro I, Keicho N, Iwamoto A, Akagawa KS. Human alveolar macrophages and granulocyte- macrophage colony-stimulating factor-induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity. J Biol Chem. 2001 ; 276: 24360-24364
97. Ulrich RG, Olson MA, Bavari S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine. 1998 ; 16: 1857-1864
98. Yu RL, Dong Z. Proinflammatory impact of Staphylococcus aureus enterotoxin B on human nasal epithelial cells and inhibition by dexamethasone. Am J Rhinol Allergy. 2009 ; 23: 15-20
99. Krakauer T, Buckley M. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock. Antimicrob Agents Chemother. 2006 ; 50: 391-395
100. Chung KF.. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001 ; 18: 50s - 59s
101. Hayworth JL, Kasper KJ, Leon-Ponte M, Herfst CA, Yue D, Brintnell WC, et al. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin. Clin Exp Immunol. 2009 ; 157: 60-70
102. Liu DY, Liu XY, Robinson D, Burnett C, Jackson C, Seele L, et al. Suppression of staphylococcal enterotoxin B-induced toxicity by a nuclear import inhibitor. J Biol Chem. 2004 ; 279: 19239-19246
103. Liu DY, Zienkiewicz J, DiGiandomenico A, Hawiger J. Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. Mol Ther. 2009 ; 17: 796-802
104. Wang S, Li Y, Xiong H, Cao J. A. broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC. Immunol Lett. 2008 ; 121: 167-172
105. Krakauer T, Buckley M. The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappa B. Immunopharm Immunot. 2008 ; 30: 163-179
106. Hale ML, Margolin SB, Krakauer T, Roy CJ, Stiles BG. Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B. Infect Immun. 2002 ; 70: 2989-2994
107. Krakauer T, Stiles BG. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release. Lab Immunol. 1999 ; 6: 594-598
108. Krakauer T, Chen X, Howard OMZ, Young HA. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharm Immunot. 2005 ; 27: 53-66